Moderna and Merck's mRNA cancer vaccine cuts death, recurrence by 42%
Late-stage win sets up regulatory talks and could reshape how cancer is treated - and how biotech investors value mRNA platforms.
By Abdullah Al-Otaibi·· 3 min

Loading the Newsroom
Curating from trusted global sources…
2 briefings · “porting”
Late-stage win sets up regulatory talks and could reshape how cancer is treated - and how biotech investors value mRNA platforms.
New global analysis finds 25% of data centers already face water stress for at least one month a year - and climate change could push that to one-third.